GLP-1 Constipation: Why It Happens and How to Get Relief

GLP-1 medications cause constipation mainly because they slow gastric emptying — the rate at which food leaves your stomach and travels through your intestines. This is the same mechanism that keeps you feeling full longer and helps you eat less, so constipation is essentially a side effect of the drug working as designed. When food moves more slowly through the colon, more water is reabsorbed from the stool, leaving it harder and drier.

There is also a second, quieter cause: you are simply eating and drinking less. Fiber and fluid are the two biggest drivers of regular bowel movements, and appetite suppression naturally cuts both. In the STEP 1 trial (NEJM 2021), 23.4% of people on semaglutide reported constipation compared with 9.5% on placebo. In SURMOUNT-1 (NEJM 2022), constipation affected roughly 17% of tirzepatide users. The good news is that for most people it is mild, most common during dose increases, and tends to settle as your body adjusts over the first two to three months.

Constipation is among the top five side effects across every major GLP-1 trial, though rates vary by drug and dose. In STEP 1, about 1 in 4 semaglutide users reported it. For tirzepatide (Mounjaro, Zepbound), SURMOUNT-1 reported constipation in roughly 17% of participants, with higher rates at the 15 mg dose. Oral semaglutide showed similar numbers.

Constipation usually peaks during the titration phase, when your dose is being stepped up every four weeks, because each increase further slows digestion before your gut adapts. It rarely leads people to stop treatment — discontinuation due to constipation alone was under 1% in most trials. If you have already dealt with other digestive side effects, our guide to [managing GLP-1 diarrhea](/blog/glp1-diarrhea-why-it-happens-and-how-to-manage-it) and [GLP-1 nausea](/blog/glp1-nausea-why-it-happens-and-how-to-ease-it) covers the flip side of the same slowed-digestion coin.

The fastest reliable relief usually comes from an osmotic laxative — either polyethylene glycol (MiraLAX) or magnesium citrate — which pulls water into the colon to soften stool, typically working within 12 to 72 hours. These are gentle, non-habit-forming, and widely recommended as first-line options for medication-related constipation.

Before reaching for a laxative, the foundation is fiber, fluid, and movement. Increase soluble fiber gradually (a sudden jump can cause bloating), drink to keup your urine pale yellow, and walk daily — physical activity stimulates the natural muscular contractions that move stool along. A short list of what tends to help most:

• •Magnesium citrate or glycinate — 200-400mg in the evening softens stool and doubles as a sleep aid
• •Polyethylene glycol (MiraLAX) — one daily dose, safe for regular use
• •Ground flaxseed or chia — 1-2 tablespoons daily for soluble fiber plus healthy fats
• •Warm liquids in the morning — coffee or warm water can trigger the gastrocolic reflex

Avoid stimulant laxatives (senna, bisacodyl) for daily use — they work but can create dependence over time.

Aim for 25-30 grams of fiber and 2-3 liters (about 8-12 cups) of water per day to keep stool soft and moving. Fiber without enough water can actually make constipation worse, so the two go together. Because GLP-1s blunt both appetite and thirst, most people fall short on both without a deliberate plan.

Soluble fiber — found in oats, beans, lentils, chia, flax, apples, and psyllium (Metamucil) — absorbs water and forms a soft gel, which is ideal for GLP-1 constipation. Insoluble fiber from vegetables and whole grains adds bulk. A practical approach is to anchor one high-fiber food to each meal and add a psyllium supplement if you still fall short. For a deeper breakdown, see our guides on [fiber on GLP-1](/blog/fiber-on-glp1-how-much-and-which-kind) and [staying hydrated on GLP-1](/blog/electrolytes-on-glp1-why-they-matter-and-how-to-get-them). Ramp fiber up slowly over one to two weeks — going from 10g to 30g overnight is a recipe for gas and bloating.

Most GLP-1 constipation is a nuisance, not a danger — but a few symptoms warrant a call to your clinician. Contact your provider if you have no bowel movement for four to five days, severe or worsening abdominal pain, persistent bloating with a firm belly, nausea and vomiting, or you cannot pass gas. In rare cases, severely slowed motility can contribute to a bowel obstruction or ileus, which the FDA has noted in post-marketing reports for GLP-1 drugs.

These serious events are uncommon, but they are the reason you should not simply ignore constipation that keeps getting worse. If constipation is severe and unrelenting despite fiber, fluids, and laxatives, your clinician may slow your dose titration or hold you at a lower dose until your gut adapts. Never stop a GLP-1 abruptly on your own without discussing it — our guide on [tapering GLP-1 safely](/blog/stopping-glp1-weight-regain-and-how-to-taper-safely) explains why. Constipation is manageable for the vast majority of people, and it rarely means the medication is wrong for you.